stars 1 stars 2 stars 3

Articulate Biosciences is a preclinical stage medical device company, developing a portfolio of products addressing indications in orthopedics and soft tissue repair. The ABX Viscoelastic product family is a series of injectable gels that are biocompatible, cushioning, and lubricating, with an initial target focus in treating osteoarthritis. Preclinical tests have demonstrated protection of cartilage and absence of adverse events in small and large animal studies. Articulate Biosciences is currently conducting additional preclinical studies in preparation for a first-in-human clinical trial. || JLABS selected company, 2018 || || Winner, 2017 Massachusetts Medical Device Development Center (M2D2) $100k Challenge || Contact: development@articulatebio.com

Articulate Biosciences Questions

The Articulate Biosciences annual revenue was $3 million in 2026.

Articulate Biosciences is based in Lowell, Massachusetts.

The NAICS codes for Articulate Biosciences are [541714, 541, 54, 54171, 5417].

The SIC codes for Articulate Biosciences are [873, 87].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users